143 related articles for article (PubMed ID: 17951293)
1. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F
Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293
[TBL] [Abstract][Full Text] [Related]
2. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.
Krüger S; Papassotiriou J; Marre R; Richter K; Schumann C; von Baum H; Morgenthaler NG; Suttorp N; Welte T;
Intensive Care Med; 2007 Dec; 33(12):2069-78. PubMed ID: 17938883
[TBL] [Abstract][Full Text] [Related]
3. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
[TBL] [Abstract][Full Text] [Related]
4. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ.
Krüger S; Ewig S; Giersdorf S; Hartmann O; Frechen D; Rohde G; Suttorp N; Welte T;
Respir Med; 2014 Nov; 108(11):1696-705. PubMed ID: 25306251
[TBL] [Abstract][Full Text] [Related]
5. CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.
Annborn M; Dankiewicz J; Nielsen N; Rundgren M; Smith JG; Hertel S; Struck J; Friberg H
Acta Anaesthesiol Scand; 2014 Apr; 58(4):428-36. PubMed ID: 24617620
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
8. Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Elmas E; Doesch C; Fluechter S; Freundt M; Weiss C; Lang S; Kälsch T; Haghi D; Papassotiriou J; Kunde J; Schoenberg SO; Borggrefe M; Papavassiliu T
Int J Cardiovasc Imaging; 2011 Apr; 27(4):547-56. PubMed ID: 20872251
[TBL] [Abstract][Full Text] [Related]
9. Outcome prediction and temperature dependency of MR-proANP and Copeptin in comatose resuscitated patients.
Broessner G; Hasslacher J; Beer R; Lackner P; Lehner GF; Harler U; Schiefecker A; Helbok R; Pfausler B; Hammerer-Lercher A; Joannidis M
Resuscitation; 2015 Apr; 89():75-80. PubMed ID: 25619444
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
[TBL] [Abstract][Full Text] [Related]
11. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia.
Seligman R; Seligman BG; Teixeira PJ
J Bras Pneumol; 2011; 37(4):495-503. PubMed ID: 21881740
[TBL] [Abstract][Full Text] [Related]
12. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D
Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656
[TBL] [Abstract][Full Text] [Related]
13. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
Vazquez M; Jockers K; Christ-Crain M; Zimmerli W; Müller B; Schuetz P
Int J Cardiol; 2012 Apr; 156(1):16-23. PubMed ID: 21093937
[TBL] [Abstract][Full Text] [Related]
14. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.
Miller WL; Hartman KA; Grill DE; Struck J; Bergmann A; Jaffe AS
Heart; 2012 Mar; 98(5):389-94. PubMed ID: 22194151
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia.
Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ
Intensive Care Med; 2008 Nov; 34(11):2084-91. PubMed ID: 18523752
[TBL] [Abstract][Full Text] [Related]
16. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
17. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
18. Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes.
Maier C; Clodi M; Neuhold S; Resl M; Elhenicky M; Prager R; Moertl D; Strunk G; Luger A; Struck J; Pacher R; Hülsmann M
Diabetes Care; 2009 Oct; 32(10):1890-5. PubMed ID: 19564455
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session.
Mueller T; Gegenhuber A; Kronabethleitner G; Leitner I; Haltmayer M; Dieplinger B
Clin Biochem; 2015 Nov; 48(16-17):1163-6. PubMed ID: 26232288
[TBL] [Abstract][Full Text] [Related]
20. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
